Qi (Kate) Wang is a seasoned professional with 20 years of experience in SAS programming within the biotech and pharmaceutical industries, specializing in various therapeutic areas including oncology and immunology. They hold a Master's degree in Biostatistics from the University of Iowa and have served in key roles at several prominent companies such as BeiGene and Genentech. Currently, Qi works as a Director at Gilead Sciences, where they lead programming teams to support clinical study objectives and regulatory submissions. Their expertise includes CDISC standards and project management, alongside a strong background in safety and efficiency analyses for phases I to IV clinical trials.
This person is not in the org chart
This person is not in any teams
This person is not in any offices